GMDTC injection for kidney protection during cisplatin chemo
Part of Cancer, Kidney & urinary clinical trials.
This trial tests an injection called GMDTC to see if it can protect the kidneys in people who already have mild kidney problems from cisplatin chemotherapy and need more cisplatin. It aims to reduce further kidney damage while continuing cancer treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a solid tumor (not kidney cancer) and have had mild kidney damage from previous cisplatin chemo.
- You must still be scheduled to receive more cisplatin chemo.
- Your kidney function must be mildly reduced, with an eGFR between 60 and 89.
- You must be able to care for yourself (ECOG score 0 or 1) and have a life expectancy of at least 6 months.
- Your blood counts and organ function (liver, heart, lungs, blood clotting) must be within acceptable levels.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a way to protect your kidneys while you receive platinum-based chemotherapy (cisplatin or carboplatin) for a solid tumor. It may help reduce the risk of kidney damage so you can complete your treatment more safely.
This study tests whether a supplement called alpha-lipoic acid can help protect your kidneys from damage caused by cisplatin, a common chemotherapy drug. If it works, it could reduce side effects and help you tolerate your cancer treatment better.
This trial tests an injectable medicine called GMDTC to help remove extra cadmium (a heavy metal) from the body. It is for people with high cadmium levels and decent kidney function, to see if the drug is safe and effective.
This trial tests a combination of two chemotherapy drugs—teniposide and cisplatin—for people who have just been diagnosed with a malignant germ cell tumor in the brain. The goal is to see if this treatment is safe and effective.
This trial tests if a supplement called L-carnitine can help prevent kidney damage caused by the chemotherapy drug cisplatin. It may be an option for newly diagnosed cancer patients who need cisplatin treatment.
This study looks at how cisplatin chemotherapy affects the kidneys. It may help doctors better predict and protect against kidney damage when patients start cisplatin.
Hear when a new Cisplatin Nephrotoxicity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.